Results 291 to 300 of about 14,613 (328)

Drug Use among Sexual and Gender Minority Populations

2020
Abstract Based on current epidemiological data, sexual and gender minorities present with significantly higher rates of drug use disorders compared with their heterosexual or cisgender counterparts. Using minority stress theory and syndemics theory, the current chapter discusses prevalence rates, psychosocial correlates, and health ...
Tyrel J. Starks, Cynthia M. Cabral, Ali J. Talan   +2 more
openaire   +1 more source

Drug Use and Sexual Activity on a College Campus

American Journal of Psychiatry, 1972
A questionnaire study on one college campus revealed that drug users were significantly more likely to engage in sexual intercourse, to engage in it earlier in life, and to engage in it regularly and with a greater variety of partners. This held true regardless of the specific indicator of drug use employed, as well as when the two control variables ...
openaire   +2 more sources

Male sexual dysfunction and psychoactive drug use

Postgraduate Medicine, 1982
(1982). Male sexual dysfunction and psychoactive drug use. Postgraduate Medicine: Vol. 71, No. 1, pp. 227-233.
openaire   +2 more sources

US drug agency approves drug for low sexual desire in women

BMJ, 2015
The US Food and Drug Administration (FDA) has approved the first drug for the treatment of women with low sexual desire. The drug, flibanserin, which is made by Sprout Pharmaceuticals, of Raleigh, North Carolina, will be marketed under the name Addyi.
openaire   +1 more source

Sexual Status and Drug Use

Journal of Drug Issues, 1973
Robert Sherwin, Kay Blackwell, Harry Kienzle   +2 more
openaire   +1 more source

Drug use and risky sexual behavior.

Psychology of Addictive Behaviors, 1994
John Schafer, Laura Blanchard, William Fals-Stewart   +2 more
openaire   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino, Roberto Carmagnani Pestana, Shanu Modi   +2 more
exaly  

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly